Related Experiment Video
Updated: Aug 10, 2025
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer
Sara Mainardi1, Rene Bernards1
1Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Abstract:
Hirt et al.1 report an automated, high-throughput drug screening platform for organoid cultures to enable repurposing of previously approved drugs for pancreatic cancers harboring specific genetic alterations. The pancreatic cancer organoid biobank also represents a valuable tool to uncover new drug-gene interactions in pancreatic tumors.
Insights
Researchers developed an automated platform for screening drugs in pancreatic cancer organoids. This enables drug repurposing for specific genetic alterations and uncovers new drug-gene interactions.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Pancreatic cancer poses significant treatment challenges.
- Developing effective therapies requires understanding drug-gene interactions.
- Organoid cultures offer a promising model for cancer research.
Discussion:
- An automated, high-throughput drug screening platform was developed for organoid cultures.
- This platform facilitates the repurposing of existing drugs for pancreatic cancers with specific genetic alterations.
- The pancreatic cancer organoid biobank is a key resource for this research.
Key Insights:
- The study demonstrates a novel approach to accelerate drug discovery in pancreatic cancer.
- Identification of potential drug candidates for genetically defined pancreatic tumors.
- Uncovering novel drug-gene interactions within pancreatic tumors.
Outlook:
- This platform can accelerate the development of personalized therapies for pancreatic cancer.
- Further research can expand the application of this platform to other cancer types.
- The organoid biobank will continue to be a valuable resource for future studies.
